Showing results (1511-1520 of 1,620) with videos related to
Sort By:
Pageof 162
Heart Rhythm|October 3, 2017
HRS Clinical Document Development Methodology Manual and Policies: Executive summaryJulia H Indik, Kristen K Patton, Marianne Beardsall, et al.Journal of Clinical Immunology|December 16, 2014
Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN diseaseFatima Dhalla, Sarah Murray, Ross Sadler, et al.Biorxiv : the Preprint Server for Biology|November 18, 2024
The Human Mitochondrial Genome Encodes for an Interferon-Responsive Host Defense PeptideM C Rice, M Imun, S W Jung, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancersAndrew L Pecora, Naiyer Rizvi, Gary I Cohen, et al.Heart Rhythm|January 21, 2015
Quality of life in pediatric patients affected by electrophysiologic diseaseRichard J Czosek, Amy E Cassedy, Jo Wray, et al.Pacing and Clinical Electrophysiology : PACE|January 11, 2003
Pacemaker therapy in isolated congenital complete atrioventricular blockJohannes M P J Breur, Floris E A Udink Ten Cate, Livia Kapusta, et al.Open Forum Infectious Diseases|September 4, 2024
Association Between Antibodies That Bind Epstein-Barr Virus (EBV) gp350 and gH/gL and Shedding of EBV in Saliva From Nasopharyngeal Carcinoma Multiplex Family Members in TaiwanKai-Lin Liu, Wan-Lun Hsu, Wei Bu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2008
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinomaAbby B Siegel, Emil I Cohen, Allyson Ocean, et al.NPJ Vaccines|September 20, 2022
KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccineCorey Casper, Lawrence Corey, Jeffrey I Cohen, et al.HIV Medicine|May 19, 2015
Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activationM Vassallo, J Durant, C Lebrun-Frenay, et al.Pageof 162